Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02144402 · ClinicalTrials.gov registry record · NA
Growth of Healthy Term Infants Fed Formula Containing DHA-B
A NA study, sponsored by dsm-firmenich Switzerland.
- Completed
- Registry status
- NA
- Development phase
- 159
- Enrollment target
NCT02144402 is a NA study that has completed, run by dsm-firmenich Switzerland. The registered enrollment target is 159 participants.
The verdict
NCT02144402, a NA study, has completed, sponsored by dsm-firmenich Switzerland.
- COMPLETED
- Registry status
- NA
- Development phase
- 159 participants
- Enrollment target
Study Summary
The primary objective is to determine if the weight gain of healthy term infants fed a commercially available term infant formula supplemented with DHASCO® is similar to that of infants fed the same formula supplemented with a new product, DHASCO®-B.
Interventions
- OTHER infant formula with DHASCO
- OTHER infant formula with DHASCO-B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02144402
The ClinicalTrials.gov registry entry for NCT02144402 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is dsm-firmenich Switzerland, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which infant formula with DHASCO is the first listed.
NCT02144402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02144402 about?
NCT02144402 is a clinical study titled "Growth of Healthy Term Infants Fed Formula Containing DHA-B". The primary objective is to determine if the weight gain of healthy term infants fed a commercially available term infant formula supplemented with DHASCO® is similar to that of infants fed the same formula supplemented with a new product, DHASCO®-B.
What is the current status of trial NCT02144402?
This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2014-05. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02144402?
The interventions under investigation include: infant formula with DHASCO (OTHER), infant formula with DHASCO-B (OTHER).
Who is sponsoring clinical trial NCT02144402?
This trial is sponsored by dsm-firmenich Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.